Actavis (ACT) Receives FDA Approval for Generic Subutex ANDA

February 20, 2015 8:46 AM

Actavis (NYSE: ACT) announced that it has received final approval from the U.S. Food and Drug Administration ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found